Reporting owner · Q3 2026 · CIK 1614740

Peetz Christopher: insider trades.

Peetz Christopher reported 13 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($7.4M), across 2 companies.

Transactions
13
Purchases (P)
0
Sales (S)
9
Companies
2
Name as filed
Peetz Christopher

Companies

CompanyRelationshipTransactions
Mirum Pharmaceuticals, Inc. (MIRM)Director, Officer · CHIEF EXECUTIVE OFFICER12
Arcutis Biotherapeutics, Inc. (ARQT)Director1

Transactions

13 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-01Mirum Pharmaceuticals, Inc.S8,312$98.08216,128Form 4
2026-09-01Mirum Pharmaceuticals, Inc.M30,000$2.94224,440Form 4
2026-09-01Mirum Pharmaceuticals, Inc.S21,688$98.91194,440Form 4
2026-08-10Mirum Pharmaceuticals, Inc.S6,017$99.25196,609Form 4
2026-08-10Mirum Pharmaceuticals, Inc.M20,000$2.94214,309Form 4
2026-08-10Mirum Pharmaceuticals, Inc.S11,683$98.51202,626Form 4
2026-08-10Mirum Pharmaceuticals, Inc.S2,300$100.14194,309Form 4
2026-07-15Arcutis Biotherapeutics, Inc.A4,315$04,315Form 4
2026-07-06Mirum Pharmaceuticals, Inc.M20,000$2.94214,309Form 4
2026-07-06Mirum Pharmaceuticals, Inc.S12,134$121.65202,175Form 4
2026-07-06Mirum Pharmaceuticals, Inc.S4,181$122.34197,994Form 4
2026-07-06Mirum Pharmaceuticals, Inc.S1,710$124.79194,309Form 4
2026-07-06Mirum Pharmaceuticals, Inc.S1,975$123.74196,019Form 4

Questions

What stock did Peetz Christopher buy or sell?

Peetz Christopher reported 13 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 0 open-market purchases and 9 sales ($7.4M), across 2 companies.

Is Peetz Christopher the same person as other filers with this name?

This page covers SEC CIK 1614740 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/peetz-christopher-1614740.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.